EC Number |
Inhibitors |
Structure |
---|
3.1.4.4 | (1S,2S)-N-[(1S)-1-methyl-2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)ethyl]-2-phenylcyclopropanecarboxamide |
- |
|
3.1.4.4 | (1S,2S)-N-[(1S)-2-[4-(4-fluoro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-1-methylethyl]-2-phenylcyclopropanecarboxamide |
- |
|
3.1.4.4 | (1S,2S)-N-[(1S)-2-[4-(5-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-1-methylethyl]-2-phenylcyclopropanecarboxamide |
- |
|
3.1.4.4 | (1S,2S)-N-[(1S)-2-[4-(5-fluoro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-1-methylethyl]-2-phenylcyclopropanecarboxamide |
- |
|
3.1.4.4 | (1S,2S)-N-[(1S)-2-[4-(6-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-1-methylethyl]-2-phenylcyclopropanecarboxamide |
- |
|
3.1.4.4 | (1S,2S)-N-[(2S)-1-[4-(5-bromo-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenylcyclopropanecarboxamide |
- |
|
3.1.4.4 | (1S,2S)-N-[2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)ethyl]-2-phenylcyclopropanecarboxamide |
- |
|
3.1.4.4 | (1S,2S)-N-[2-[4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]ethyl]-2-phenylcyclopropanecarboxamide |
- |
|
3.1.4.4 | (1S,2S)-N-[2-[4-(5-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]ethyl]-2-phenylcyclopropanecarboxamide |
- |
|
3.1.4.4 | 1,2-bis(2-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl) ester |
i.e. BAPTA-AM, chelator of intracellular free calcium, application results in reduction of extracellular pH-induced enzyme activity |
|